Cronos Group (TSE:CRON) Shares Up 4.6% – Should You Buy?

Shares of Cronos Group Inc. (TSE:CRON) rose 4.6% on Monday . The stock traded as high as C$4.52 and last traded at C$4.52. 111,264 shares were traded during mid-day trading, a decline of 34% from the average daily volume of 169,367 shares. The stock had previously closed at C$4.32.

Analyst Upgrades and Downgrades

Separately, TD raised their target price on shares of Cronos Group from C$5.50 to C$6.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, Cronos Group has an average rating of “Buy” and a consensus target price of C$4.92.

Cronos Group Price Performance

The firm has a market capitalization of C$1.67 billion, a P/E ratio of 23.79, a P/E/G ratio of 0.12 and a beta of 1.30. The firm’s 50 day simple moving average is C$4.25 and its two-hundred day simple moving average is C$3.88. The company has a debt-to-equity ratio of 0.12, a current ratio of 16.18 and a quick ratio of 24.01.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.